On 22 April 2013 the independent data safety monitoring board (DSMB) conducted a scheduled interim review of unblinded data from the study [REF].
The DSMB review also noted that more persons who received the vaccine became infected than those in the control group - 41 persons among the vaccinated and 30 among the placebo recipients [REF].